Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2014 | 2016 | ||||||||
|
acyl-CoA dehydrogenase family member 10 | 0.760 | 0.308 | 1.0E-30 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ADAMTS9 antisense RNA 2 | 0.656 | 0.462 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
aldehyde dehydrogenase 1 family member A2 | 0.578 | 0.692 | 0.36 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 1998 | 2016 | ||||||||
|
Rho GTPase activating protein 21 | 0.722 | 0.308 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
age-related maculopathy susceptibility 2 | 0.670 | 0.308 | 5.2E-04 |
|
disease | 0.200 | None | 1.000 | 4 | 2 | 2008 | 2017 | ||||||||
|
beta 3-glucosyltransferase | 0.554 | 0.731 | 7.1E-17 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
C2 antisense RNA 1 | 0.821 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 2010 | 2016 | ||||||||
|
chromosome 6 open reading frame 223 | 0.890 | 0.038 | 5.1E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
complement C9 | 0.619 | 0.692 | 1.6E-24 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
disease | 0.110 | None | 1.000 | 2 | 3 | 2015 | 2016 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2008 | 2016 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
disease | 0.200 | None | 0.982 | 4 | 7 | 2005 | 2018 | ||||||||
|
complement factor H related 5 | 0.659 | 0.385 | 2.1E-32 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
complement factor I | 0.569 | 0.731 | 3.5E-08 |
|
disease | 0.110 | None | 0.500 | 1 | 2 | 2014 | 2016 | ||||||||
|
calponin 2 | 0.666 | 0.538 | 2.4E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
collagen type IV alpha 3 chain | 0.552 | 0.692 | 1.1E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
collagen type VIII alpha 1 chain | 0.678 | 0.538 | 0.41 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2016 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 3 | 5 | 2012 | 2016 | ||||||||
|
exocyst complex component 3 like 2 | 0.722 | 0.500 | 0.76 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
exocyst complex component 5 | 0.805 | 0.269 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
FYVE, RhoGEF and PH domain containing 6 | 0.792 | 0.192 | 2.4E-08 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 |